Stay updated on Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.

Latest updates to the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice about potential delays due to a lapse in government funding and the revised page version tag (v3.4.1) were added, while the previous tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check9 days agoChange DetectedAdded a glossary display option and color-coded history highlights, and updated the revision label to v3.4.0 with minor wording changes (e.g., 'No FEAR Act Data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry v3.3.4 was added and the previous v3.3.3 was removed in the Record History for NCT04150965. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2 in the footer, representing minor metadata updates rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check73 days agoChange DetectedThe page history now shows Revision: v3.3.2 and removes Revision: v3.2.0 from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedRemoved the generic government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.